We and others have demonstrated that prostate-specific membrane antigen (PSMA) and P-glycoprotein (P-gp) encoded by multi-drug resistance protein 1 (MDR1) expressed on the surface of blood exosomes could be a marker for PC and taxane-resistant CRPC, respectively [12–15]. This evidence concerns the gene FOLH1 and pachyonychia congenita.